Clinical Trial Update: Efficacy and Safety of Ramelteon on Chronic Insomnia [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the efficacy and safety of ramelteon for chronic insomnia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• ROZEREM (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Chronic Insomnia | Phase 2 | Status: COMPLETED